Registration Strip Icon for default Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.

Disc Medicine Inc

IRON
55,67
0,17 (0,31%)
08 Mar 2025 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
03/3/202522:01EDGAR2Form SCHEDULE 13D/A - General Statement of Acquisition of..
27/2/202514:56EDGAR2Form S-8 - Securities to be offered to employees in employee..
27/2/202514:17EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
27/2/202514:11EDGAR2Form 8-K - Current report
27/2/202514:00GLOBEDisc Medicine Reports Fourth Quarter and Full Year 2024..
26/2/202514:00GLOBEDisc Medicine to Participate in Upcoming Investor..
21/2/202501:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/2/202501:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/2/202500:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/2/202500:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/2/202515:08EDGAR2Form SCHEDULE 13G - Statement of Beneficial Ownership by..
04/2/202523:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/1/202522:09EDGAR2Form 8-K - Current report
23/1/202523:24EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
23/1/202503:35GLOBEDisc Medicine Announces Pricing of $225.5 Million Upsized..
21/1/202523:24EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
21/1/202522:01GLOBEDisc Medicine Announces Proposed Public Offering of Common..
21/1/202513:52EDGAR2Form 8-K - Current report
21/1/202513:45GLOBEDisc Medicine Announces Successful Type C Meeting with FDA..
21/1/202501:00GLOBEDisc Medicine to Host Conference Call on Type C Meeting for..
17/1/202522:00GLOBEDisc Medicine Reports Inducement Grant under Nasdaq Listing..
10/1/202515:04EDGAR2Form 8-K - Current report
10/1/202515:00GLOBEDisc Medicine Highlights Recent Achievements Across..
06/1/202523:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/1/202522:20EDGAR2Form 144 - Report of proposed sale of securities
09/12/202418:00GLOBEDisc Medicine Presents Positive Clinical and Translational..
09/12/202414:48EDGAR2Form 8-K - Current report
09/12/202402:00GLOBEDisc Medicine Presents Positive Updated Results from Phase..
27/11/202402:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/11/202422:46EDGAR2Form 144 - Report of proposed sale of securities
20/11/202400:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/11/202422:47EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
15/11/202422:43EDGAR2Form POS AM - Post-Effective amendments for registration..
15/11/202422:39EDGAR2Form 144 - Report of proposed sale of securities
15/11/202422:31EDGAR2Form 8-K - Current report
14/11/202423:44EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
14/11/202422:33EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
13/11/202414:30GLOBEDisc Medicine to Participate in Upcoming Investor..
12/11/202414:00GLOBEDisc Medicine Reports Third Quarter 2024 Financial Results..
08/11/202414:49EDGAR2Form 8-K - Current report
08/11/202414:30GLOBEDisc Medicine Secures $200 Million in Non-Dilutive Debt..
05/11/202415:00GLOBEDisc Medicine Announces Multiple Presentations Across..
04/11/202413:55EDGAR2Form 8-K - Current report
04/11/202413:50GLOBEDisc Medicine Announces Successful End of Phase 2 Meeting..
01/11/202421:01GLOBEDisc Medicine to Host Conference Call on End of Phase 2 FDA..
25/10/202419:11EDGAR2Form 8-K - Current report
25/10/202419:00GLOBEDisc Medicine Presents Positive Data from SAD Cohorts of a..
23/10/202414:00GLOBEDisc Medicine Appoints Seasoned Industry Executive Rahul..
11/10/202414:00GLOBEDisc Medicine Announces Presentation of New Data from Phase..
19/9/202414:30GLOBEDisc Medicine Expands Leadership Team with Appointment of..
Apertura: 54,78 Min: 54,755 Max: 57,04
Chiusura: 55,50

La tua Cronologia

Delayed Upgrade Clock

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network